Gemtuzumab for Named Patient Import

Gemtuzumab for Indian Patients

Gemtuzumab ozogamicin is a very advanced medication in the management of Hematological malignancies, duly approved by FDA. Acute myeloid leukemia is the indication for which Hematologists recommend this drug, even in India. Both adult and pediatric groups of patients benefit from this monoclonal antibody drug. This new generation medication is the product of Pfizer and is available as Mylotarg, its trade name. Mylotarg 5mg is the commercially accessible from the counties that approved it.

Gemtuzumab or Mylotarg in India can’t be procured through routine domestic chemotherapy suppliers. This is because Mylotarg in India is not registered for commercial trade and distribution. But, Indian patients can always utilize the provisions of Named Patient Import to obtain Gemtuzumab ozogamicin. Mylotarg is usually available as 5mg vials and the same can be sourced through international distributors in limited quantities for personal use.

Gemtuzumab in India? Take expert guidance.

When your Hematologist or primary consultant recommends Gemtuzumab or Mylotarg, there is a clear need to administer this drug on a priority basis. We encourage you to consider our expert assistance. We will provide you all the probable options to reach out to some of the highly authentic sources. These sources are duly licensed and therefore can be trusted with previous experience of facilitating Gemtuzumab ozogamicin supply in India. There is no need to be confused or stressed with the documentation process, no matter how complex it may seem to be. The support we extend is comprehensive and end to end, all through the process.

Kindly Email to nhs@noelbiotech.com or call us on + 91 9677010046 / + 91 9929277766.